Respimat inhaler

March 29, 2016May 13, 2016

Digital Aid to Manage COPD and Asthma Being Made Available to RESPIMAT Inhaler Users

Asthma, COPD, News

Propeller Health and Boehringer Ingelheim Pharmaceuticals recently announced a commercial collaboration, based on joint use of the companies’ health tools and services, in an effort to help people better manage long-term lung conditions like asthma and ... Read more

July 22, 2015November 9, 2015

FDA Approves Propeller Health Mobile Platform for GlaxoSmithKline’s Diskus DPI and Boehringer’s Respimat Inhaler

COPD, News

Propeller Health, a leading mobile platform for respiratory health management that utilizes sensors, mobile apps and services to help reduce the cost of care while improving quality of life for individuals ... Read more

February 26, 2015November 6, 2015

Boehringer Presents New Phase III Data for Asthma Therapy Tiotropium

Asthma, News

Pharmaceutical company Boehringer Ingelheim recently presented encouraging data regarding its investigational drug tiotropium delivered through the company’s Respimat inhaler, for the treatment of asthma. The data was presented at the 2015 American Academy of Allergy, Asthma & Immunology ... Read more

November 5, 2014November 6, 2015

FDA Agrees To Review Spiriva Respimat By Boehringer Ingelheim To Treat Asthma

Asthma, News

The Food and Drug Administration (FDA) recently agreed to review a new drug application (NDA) by Boehringer Ingelheim for Spiriva Respimat (tiotropium bromide) Inhalation Spray to treat asthma. Spiriva Respimat is an experimental therapy ... Read more

June 10, 2014November 11, 2015

Boehringer Ingelheim Reports First Data Of Tiotropium and Olodaterol Fixed-Dose Combination in COPD

COPD, News

Boehringer Ingelheim recently announced the results of the Phase III VIVACITO® study investigating the effect of tiotropium and olodaterol fixed-dose combination (T+O FDC) delivered by the Respimat inhaler to improve lung ... Read more